Loading…
Sunday June 29, 2025 4:30pm - 5:30pm EDT
Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease dementia, and Lewy body dementia share pathological and clinical features. This session discusses the co-pathologies and the use of blood, skin, cerebrospinal fluid, and other biomarkers to aid in the differential diagnosis, and treatments to be considered including whether to split into individual pathology or clusters. Treatments to be considered include the targeting of amyloid beta for Alzheimer’s disease.
CME Faculty
avatar for Richard S. Isaacson, MD

Richard S. Isaacson, MD

Institute for Neurodegenerative Diseases
Richard S. Isaacson, MD, is a preventive neurologist and clinician researcher in the field of Alzheimer’s prevention. He founded and directed the first Alzheimer’s Prevention Clinic (APC) in the U.S. in 2013 at Weill Cornell Medicine/NewYork-Presbyterian, where he also served... Read More →
avatar for David Shprecher, DO Msci, FAAN

David Shprecher, DO Msci, FAAN

Banner Sun Health Research Institute
David Shprecher, DO, MSci, FAAN is Movement Disorders Director for Banner Research and Clinical Associate Professor for University of Arizona-Phoenix.  Dr. Shprecher completed a doctor of osteopathic medicine degree at Lake Erie College of Osteopathic Medicine and a Neurology residency... Read More →
avatar for Yasar Torres-Yaghi, MD

Yasar Torres-Yaghi, MD

ATMRD Course Director, MedStar Georgetown University Hospital
Yasar Torres Yaghi, MD is a board-certified neurologist at the MedStar Georgetown University Hospital in Washington, DC and Co-Director of the Lewy Body Dementia Clinic. He obtained his medical degree from George Washington University School of Medicine, and subsequently completed... Read More →
Sunday June 29, 2025 4:30pm - 5:30pm EDT
Woodrow Wilson B-D

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link